Review

Fatty Heart, Cardiac Damage, and Inflammation

Maria A. Guzzardi, Patricia Iozzo

Manuscript submitted July 25, 2011; resubmitted September 21, 2011; accepted September 27, 2011.

Keywords: type 2 diabetes, obesity, cardiovascular disease, imaging, ectopic fat, epicardial fat, lipid, lipotoxicity

Abstract

Type 2 diabetes and obesity are associated with systemic inflammation, generalized enlargement of fat depots, and uncontrolled release of fatty acids (FA) into the circulation. These features support the occurrence of cardiac adiposity, which is characterized by an increase in intramyocardial triglyceride content and an enlargement of the volume of fat surrounding the heart and vessels. Both events may initially serve as protective mechanisms to portion energy, but their excessive expansion can lead to myocardial damage and heart disease. FA overload promotes FA oxidation and the accumulation of triglycerides and metabolic intermediates, which can impair calcium signaling, β-oxidation, and glucose utilization. This leads to damaged mitochondrial function and increased production of reactive oxygen species, pro-apoptotic, and inflammatory molecules, and finally to myocardial inflammation and dysfunction. Triglyceride accumulation is associated with left ventricular hypertrophy and dysfunction. The enlargement of epicardial fat in patients with metabolic disorders, and coronary artery disease, is associated with the release of proinflammatory and proatherogenic cytokines to the subtending tissues. In this review, we examine the evidence supporting a causal relationship linking FA overload and cardiac dysfunction. Also, we disentangle the separate roles of FA oxidation and triglyceride accumulation in causing cardiac damage. Finally, we focus on the mechanisms of inflammation development in the fatty heart, before summarizing the available evidence in humans. Current literature confirms the dual (protective and detrimental) role of cardiac fat, and suggests prospective studies to establish the pathogenetic (when and how) and possible prognostic value of this potential biomarker in humans.

Fulltext: HTML , PDF (1.2 MB)

This article has been cited by other articles:

	Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop Colasante C, Chen J, Ahlemeyer B, Baumgart-Vogt E Thromb Haemost 2015. 113(3):452-463
	Effect of vitamin D deficiency and supplementation on myocardial deformation parameters and epicardial fat thickness in patients free of cardiovascular risk Sunbul M, Bozbay M, Mammadov C, Cincin A, Atas H, Ozsenel EB, Sari I, Basaran Y Int J Cardiovasc Imaging 2015. In press
	Imaging of Organ Metabolism in Obesity and Diabetes: Treatment Perspectives Hannukainen J, Guzzardi M, Virtanen K, Sanguinetti E, Nuutila P, Iozzo P Curr Pharm Des 2014. 20(39):6126-6149
	Hemoglobin-associated oxidative stress in the pericardial compartment of postoperative cardiac surgery patients Kramer PA, Chacko BK, Ravi S, Johnson MS, Mitchell T, Barnes S, Arabshahi A, Dell'Italia LJ, George DJ, Steele C, George JF, Darley-Usmar VM, Melby SJ Lab Invest 2014. In press
	The effect of obstructive sleep apnea on QRS complex morphology Bacharova L, Triantafyllou E, Vazaios C, Tomeckova I, Paranicova I, Tkacova R J Electrocardiol 2014. In press
	Impact of diabetes mellitus on myocardial lipid deposition: an autopsy study Nakanishi T, Kato S Pathol Res Pract 2014. 210(12):1018-1025
	Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease? Chouinard-Watkins R, Plourde M Nutrients 2014. 6(10):4452-4471
	Independent effects of circulating glucose, insulin and NEFA on cardiac triacylglycerol accumulation and myocardial insulin resistance in a swine model Guzzardi MA, Hodson L, Guiducci L, Sanguinetti E, Di Cecco P, Liistro T, Vassalle C, Pardini S, Giorgetti L, Salvadori PA, Burchielli S, Iozzo P Diabetologia 2014. 57(9):1937-1946
	Epicardial fat thickness in stable coronary artery disease: its relationship with high-sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide Börekci A, Gür M, Özaltun B, Baykan AO, Harbalioglu H, Seker T, Sen Ö, Acele A, Gözükara MY, Kuloglu O, Koc M, Cayli M Coron Artery Dis 2014. 25(8):685-690
	Roles of chronic low-grade inflammation in the development of ectopic fat deposition Liu L, Mei M, Yang S, Li Q Mediators Inflamm 2014. 2014:418185
	Increased myocardial dysfunction, dyssynchrony, and epicardial fat across the lifespan in healthy males Crendal E, Dutheil F, Naughton G, McDonald T, Obert P BMC Cardiovasc Disord 2014. 14:95
	Right ventricle free wall mechanics in metabolic syndrome without type-2 diabetes: effects of a 3-month lifestyle intervention program Serrano-Ferrer J, Walther G, Crendal E, Vinet A, Dutheil F, Naughton G, Lesourd B, Chapier R, Courteix D, Obert P Cardiovasc Diabetol 2014. 13:116
	Arrhythmia Risk and Obesity Mozos I J Mol Genet Med 2014. S1
	Epicardial fat: more than just an "epi" phenomenon? Gaborit B, Abdesselam I, Dutour A Horm Metab Res 2013. 45(13):991-1001
	Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity Opinto G, Natalicchio A, Marchetti P Arch Physiol Biochem 2013. 119(4):170-178
	Epicardial fat and vascular risk: a narrative review Katsiki N, Mikhailidis DP, Wierzbicki AS Curr Opin Cardiol 2013. 28(4):458-463
	The efficacy and tolerability of azilsartan in obese insulin-resistant mice with left ventricular pressure overload Tarikuz Zaman AK, McLean DL, Sobel BE J Cardiovasc Pharmacol 2013. 62(4):381-387
	Low total testosterone levels are associated with the metabolic syndrome in elderly men: the role of body weight, lipids, insulin resistance, and inflammation; the Ikaria study Chrysohoou C, Panagiotakos D, Pitsavos C, Siasos G, Oikonomou E, Varlas J, Patialiakas A, Lazaros G, Psaltopoulou T, Zaromitidou M, Kourkouti P, Tousoulis D, Stefanadis C Rev Diabet Stud 2013. 10(1):27-38
	Seeing is believing: dietary fatty acids hurry up from the stomach to the heart of patients with impaired glucose tolerance Iozzo P Diabetes 2012. 61(11):2659-2660
	Is spinal osteophytosis associated with fatty liver? Rozin AP, Gaitini D, Toledano K, Balbir-Gurman A Rheumatol Rep 2012. 4(1):e4
	Acute effects of dietary fat on inflammatory markers and gene expression in first-degree relatives of type 2 diabetes patients Pietraszek A, Gregersen S, Hermansen K Rev Diabet Stud 2011. 8(4):477-489
	Physiology of incretins in health and disease Deacon CF, Ahren B Rev Diabet Stud 2011. 8(3):293-306
	The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS Special Issue Raz I, Gallwitz B Rev Diabet Stud 2011. 8(3):288-292